GLP‑1 adoption is expanding, but a start‑stop user base is accelerating existing shifts in how consumers eat and how food ...

The company is seeking to expand its resources for patients on GLP-1s, including tracking medication and biometrics with Ōura ...

There is no shortage of headlines about GLP-1 medications. Originally developed to manage blood sugar levels, these medications are now widely known for promoting weight loss. Alongside their rapid ...

Experts describe the development of oral GLP-1 medication as a “pivotal” improvement in the accessibility and adherence to obesity drugs. As of February 2026, only Wegovy and Rybelsus are available in ...

Eli Lilly remains central to healthcare discussion as its oral GLP-One pill advances through pivotal trials for obesity and ...

New evidence shows that GLP-1–based therapies not only lower glucose levels and aid in weight loss but also reduce inflammation in the heart, kidneys, liver, and brain, revealing a broader therapeutic ...

The UC Davis Innovation Institute for Food and Health recently hosted scientists, physicians and industry experts to discuss how drugs based on GLP-1 are transforming treatment for obesity, diabetes ...

GLP-1 has become a popular buzzword in the weight-loss community — but now some are touting "GLP-3s," claiming they are taking obesity medications to the next level. GLP-1 (glucagon-like peptide-1) ...

GLP-1 medications, such as Ozempic and Wegovy, are injected into the fatty layer beneath the skin to manage blood sugar and aid in weight management. The recommended injection sites include the ...

GLP-1 stocks are an interesting option for investors, as GLP-1 drugs are transforming healthcare in the modern age. Initially developed for type 2 diabetes, these drugs have demonstrated significant ...